Monthly Archives: July 2018

In late June, Glaukos (an ophthalmic medical technology company focused directly on the treatment of glaucoma) announced that the FDA had approved the much anticipated iStent inject® Trabecular Micro-Bypass System (or the iStent inject, for short) for patients with mild-to-moderate primary open-angle glaucoma. We are delighted to share that our very own Dr. Thomas W…. Read More

This time of year is always bittersweet as we say ‘goodbye’ to the Fellow physicians who have been with us this past year, and ‘hello’ to the incoming 2018-2019 Fellows! Dr. Walter T. Parker (our MD Fellow) will be returning to Alabama and joining Alabama Ophthalmology Associates in Birmingham. We will certainly miss him at… Read More

The Optical Departments located within the Bloomington office and adjacent to our Minneapolis office (Park Optical) are now closed. We apologize for any inconvenience this may cause, and would like to suggest visiting one of our Preferred Optical Partners for your future optical needs.  Commonly Asked Questions/Answers: Q: Can I still see my MEC eye… Read More

  Cataracts, the leading cause of blindness in the world are a common age-related condition. Nearly 25 million Americans who are 40 and over develop cataracts, a clumping of proteins in the lens, which causes cloudy or blurry vision, and can eventually result in loss of vision. Even though cataracts are a very common condition… Read More